# Martin Citron

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/martin-citron/

## Facts

| Field | Value |
| --- | --- |
| Citations | 26,230 |
| Field | Alzheimer's disease research and treatments |
| h-index | 56 |
| i10-index | 81 |
| Last Known Institution | UCB Pharma (Belgium) |
| OpenAlex ID | https://openalex.org/A5004033835 |
| ORCID iD | https://orcid.org/0000-0001-6893-8204 |
| Works | 123 |

## Researcher papers

- [Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease](https://scholariq.org/papers/secreted-amyloid-protein-similar-to-that-in-the-senile-plaques-of-alzheimer-s/)

## Researcher topics

- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)
- [Computational Drug Discovery Methods](https://scholariq.org/topics/computational-drug-discovery-methods/)
- [Cholinesterase and Neurodegenerative Diseases](https://scholariq.org/topics/cholinesterase-and-neurodegenerative-diseases/)
- [Drug Transport and Resistance Mechanisms](https://scholariq.org/topics/drug-transport-and-resistance-mechanisms/)
- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)

## Researcher university

- [UCB Pharma (Belgium)](https://scholariq.org/institutions/ucb-pharma-belgium/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.